Cobalamin
As of the edition of 20 October 2026, Cobalamin is a small molecule: marketed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Small molecule
- Brand name
- Vitamin B12 Wörwag
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Wörwag Pharma Gmbh & Co. Kg
- Registered trials
- 3, 0 stopped early
- Disease areas
- Blood and lymph; Cancer; Hormones; Mental health; Nervous system; Nutrition and metabolism
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 3 | 2 | 1 | 0 | 0 |
| Phase 4 | 1 | 0 | 0 | 0 |
| All trials | 3 |
Who ran its trials
| Company | Role | Years |
|---|---|---|
| Merck KGaA | Lead sponsor of trials | 2008 to now |